This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Quality of Life  • Liver/ Biliary Tract/ Pancreatic Diseases  • Viral Infections  • Transplantation  • Liver Transplantation  • Perspectives on Care at the Close of Life  • Patient-Physician Communication  • End-of-life Care/ Palliative Medicine  • Alert me on articles by topic

"Too Well for Transplant, Too Sick for Life"

Anne M. Larson, MD; J. Randall Curtis, MD, MPH

JAMA. 2006;295:2168-2176.

Chronic liver disease results in more than 1 million physician visits and more than 300 000 hospitalizations per year in the United States. More than 27 000 patients annually progress to end-stage liver disease (ESLD), liver failure, or death. Patients with ESLD experience such complications as encephalopathy, malnutrition, muscle wasting, ascites, esophagogastric variceal hemorrhage, spontaneous bacterial peritonitis, fatigue, and depression. Despite significant improvements in palliation, patients' quality of life diminishes and their disease will often inexorably progress. Liver transplantation, a valid treatment option, increases life and reduces many symptoms. With the current shortage of organs, up to 10% to 15% of these patients die without receiving an organ. Many patients also are not candidates for transplantation due to comorbid illness. In addition, some patients receive a transplant but succumb to complications of the transplant itself. Such patients and families face the conundrum of a potentially treatable yet often fatal illness. Through the case of a 55-year-old woman with a life-long history of hepatitis B virus infection who is awaiting transplant, we discuss the transplant eligibility process and the struggle with maintaining hope for a cure in the face a life-threatening illness. In all of these circumstances, the health care team must combine elements of palliative care with life-sustaining therapy to maximize the patient's quality and quantity of life.

Author Affiliations: Department of Medicine, School of Medicine, University of Washington, Seattle.

RELATED ARTICLE

Liver Transplantation
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2006;295(18):2208.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best"
Mitsumoto and Rabkin
JAMA 2007;298:207-216.
ABSTRACT | FULL TEXT  

Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life".
Markowitz and McPhee
JAMA 2006;295:2655-2655.
FULL TEXT